Growth hormone hypersensitivity is characterized by enhanced growth due to an enhanced stimulation of the receptor by the hormone. One variation causing deletion or non transcription of exon 3 is made responsible for this abnormality.
Disorders of the growth control system | ||||
ADAMTSL3 | ||||
Combined pituitary hormone deficiency | ||||
Growth hormone deficiency | ||||
Growth hormone hypersensitivity | ||||
GHR | ||||
Growth hormone insensitivity | ||||
1. |
Leung DW et al. () Growth hormone receptor and serum binding protein: purification, cloning and expression. |
2. |
Asa SL et al. (2007) A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors. |
3. |
Schreiner F et al. (2007) Association of the growth hormone receptor d3-variant and catch-up growth of preterm infants with birth weight of less than 1500 grams. |
5. |
Räz B et al. (2008) Influence of growth hormone (GH) receptor deletion of exon 3 and full-length isoforms on GH response and final height in patients with severe GH deficiency. |
6. |
van der Klaauw AA et al. (2008) Influence of the d3-growth hormone (GH) receptor isoform on short-term and long-term treatment response to GH replacement in GH-deficient adults. |
8. |
Mercado M et al. (2008) Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly. |
9. |
Amselem S et al. (1991) Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism. |
10. |
Rubin CJ et al. (2010) Whole-genome resequencing reveals loci under selection during chicken domestication. |
11. |
Rosenbloom AL et al. (1990) The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador. |
12. |
Arden KC et al. (1990) The receptors for prolactin and growth hormone are localized in the same region of human chromosome 5. |
13. |
Barton DE et al. (1989) Chromosome mapping of the growth hormone receptor gene in man and mouse. |
14. |
Amselem S et al. (1989) Laron dwarfism and mutations of the growth hormone-receptor gene. |
15. |
Laron Z et al. (1989) Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism. |
16. |
Godowski PJ et al. (1989) Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. |
17. |
Goddard AD et al. (1995) Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group. |
18. |
Spencer SA et al. (1988) Rabbit liver growth hormone receptor and serum binding protein. Purification, characterization, and sequence. |
19. |
Edery M et al. (1993) Lack of hormone binding in COS-7 cells expressing a mutated growth hormone receptor found in Laron dwarfism. |
20. |
Berg MA et al. (1993) Diverse growth hormone receptor gene mutations in Laron syndrome. |
21. |
Woods KA et al. (1996) A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein. |
22. |
Stallings-Mann ML et al. (1996) Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism. |
23. |
Menon RK et al. (1997) Identification and characterization of single strand DNA-binding protein that represses growth hormone receptor gene expression. |
24. |
Kaji H et al. (1997) Novel compound heterozygous mutations of growth hormone (GH) receptor gene in a patient with GH insensitivity syndrome. |
25. |
Amit T et al. (1997) A membrane-fixed, truncated isoform of the human growth hormone receptor. |
28. |
Rosenbloom AL et al. (1998) Stature in Ecuadorians heterozygous for growth hormone receptor gene E180 splice mutation does not differ from that of homozygous normal relatives. |
29. |
Shen XY et al. (1998) Cirrhotic liver expresses low levels of the full-length and truncated growth hormone receptors. |
31. |
Sanchez JE et al. (1998) Growth hormone receptor mutations in children with idiopathic short stature. |
34. |
Horan M et al. (2006) Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke. |
36. |
Ayling RM et al. (1997) A dominant-negative mutation of the growth hormone receptor causes familial short stature. |
37. |
Iida K et al. (1999) Functional characterization of truncated growth hormone (GH) receptor-(1-277) causing partial GH insensitivity syndrome with high GH-binding protein. |
38. |
Shuto Y et al. (1999) Reduced growth hormone receptor messenger ribonucleic acid in an aged man with chronic malnutrition and growth hormone resistance. |
39. |
Amit T et al. (2000) Clinical review 112: Does serum growth hormone (GH) binding protein reflect human GH receptor function? |
40. |
Pantel J et al. (2000) Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. |
41. |
Ballesteros M et al. (2000) Distribution and abundance of messenger ribonucleic acid for growth hormone receptor isoforms in human tissues. |
42. |
Stofega MR et al. (2000) Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B. |
43. |
Gastier JM et al. (2000) Diverse deletions in the growth hormone receptor gene cause growth hormone insensitivity syndrome. |
44. |
Leung KC et al. (2000) Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. |
45. |
Fisker S et al. (2001) Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatment. |
46. |
Metherell LA et al. (2001) Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity. |
47. |
Jorge AA et al. (2002) Poor reproducibility of IGF-I and IGF binding protein-3 generation test in children with short stature and normal coding region of the GH receptor gene. |
48. |
Marzullo P et al. (2002) Leptin concentrations in GH deficiency: the effect of GH insensitivity. |
50. |
Berg MA et al. (1992) Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome. |
52. |
Milward A et al. (2004) Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction. |
53. |
Dos Santos C et al. (2004) A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. |
54. |
Tiulpakov A et al. (2005) A novel C-terminal growth hormone receptor (GHR) mutation results in impaired GHR-STAT5 but normal STAT-3 signaling. |
55. |
Greenhalgh CJ et al. (2005) SOCS2 negatively regulates growth hormone action in vitro and in vivo. |
57. |
Binder G et al. (2006) The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. |
60. |
Kenth G et al. (2007) Relationship of the human growth hormone receptor exon 3 genotype with final adult height and bone mineral density. |
61. |
David A et al. (2007) An intronic growth hormone receptor mutation causing activation of a pseudoexon is associated with a broad spectrum of growth hormone insensitivity phenotypes. |
62. |
Duquesnoy P et al. (1991) Defective membrane expression of human growth hormone (GH) receptor causes Laron-type GH insensitivity syndrome. |
63. |
Jensen RB et al. (2007) The presence of the d3-growth hormone receptor polymorphism is negatively associated with fetal growth but positively associated with postnatal growth in healthy subjects. |
64. |
OMIM.ORG article Omim 600946 |